Abstract
Background
Esophageal cancer is associated with a poor long-term prognosis. Only a 10% 5-year survival rate is reported. This article aims to evaluate the feasibility and efficacy of laparoscopic esophagectomy for the palliative treatment of advanced esophageal cancer (T3-T4 Nx-N1) after neoadjuvant therapy.
Methods
From March 1998 to July 2002, 35 patients (mean age, 64.6 years; range, 35–72 years) affected by advanced cancer of the middle lower third of the esophagus came to the authors’ observation. All received neoadjuvant radiochemotherapy. Of the 35 patients, 22 (62.9%) showed a positive response to treatment (≥50% reduction of maximal cross-sectional area of the tumor), and surgical intervention was performed 4 weeks after the end of the therapy. The operations were accomplished through the laparoscopic approach and left lateral cervicotomy.
Results
The mean operative time was 160 min (range, 120–260 min). One patient (4.5%) experienced a cervical anastomotic leak. Three patients (13.6%) died in the postoperative period: one of myocardial infarction and two of acute respiratory failure. The mean postoperative hospital stay was 12.1 days (range, 9–23 days). After a mean follow-up period of 20.2 months (range, 10–40 months), 13 patients (68.4%) were alive.
Conclusions
The laparoscopic approach seems to be effective for the palliative treatment of advanced esophageal cancer. Further trials will be necessary to evaluate the advantages of this technique.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Despite aggressive surgical interventions, esophageal cancer still is associated with a poor long-term outcome. Only a 10% rate of 5-year survival is reported [26].
Conventional approaches involving thoracotomy, laparotomy, or both are associated with high morbidity and mortality rates and delay in return to normal activity [28, 36].
Advances in minimally invasive surgery with its known benefits in terms of operative morbidity, shorter hospital stay, and more rapid recovery, have led some surgeons to explore the possibility of performing total esophagectomy by the laparoscopic approach [10, 24, 39]. Their results seem to demonstrate that this technique was feasible and safe in centers with great laparoscopic experience [10, 24, 39].
On the basis of their reports, since November 1998, we have managed locally advanced (T3-T4/Nx-N1) squamous cell carcinomas of the middle lower third of the esophagus by the laparoscopic approach, after neoadjuvant chemoradiotherapy.
Materials and methods
From March 1998 to July 2002, 35 patients (20 men and 15 women; mean age, 64.6 years; range, 35–72 years) affected by a locally advanced squamous cell carcinoma (T3-T4/Nx-N1) of the middle lower third of the esophagus (6 pts T3N0, 18 T3N1, 11 T4N1) came to our observation. Complete pretreatment evaluation included barium esophagogram, esophagogastric endoscopic examination, esophageal endoscopic ultrasound, and computed tomography scan of the neck, chest, and abdomen. Bronchoscopy was performed if there was suspicion of tracheal carina infiltration. All the patients received a combined neoadjuvant chemoradiotherapy and completed the 4 weeks treatment. Chemotherapy consisted of 5-FU 1,000 mg/m2 by 24-h infusion for 4 days and CDDP 100 mg/m2 on day 1 in the first and the fourth weeks. Concurrent radiotherapy was delivered at a total dose of 40 Gy in daily fractions of 2 Gy five times a week. Four weeks after the end of the treatment, the patients were reevaluated by endoscopic ultrasound and computed tomography scan and underwent surgery depending on the response to the neoadjuvant therapy.
Operative technique
The patient is placed in a supine, reversed Trendelenburg position with the legs abducted and the surgeon standing between the patient’s legs. The first assistant is at the right of the surgeon, and the second is at the left with the camera on his right arm. After induction of a 12-mmHg pneumoperitoneum with a Veress needle introduced at the umbilicus, a first 10-mm trocar is inserted at the same site. The camera explores the abdominal cavity, verifying the absence of peritoneal spread or hepatic metastases. Then, under direct vision, a second 5-mm trocar is placed in the right subcostal space on the midclavear line, and a third 5-mm trocar in the epigastrium on the left of round ligament. A 10-mm trocar is inserted in the left subcostal space on the midclavear line, and the last 10-mm trocar is placed on the transverse umbilical line at the left of camera port (Fig. 1).
The stomach mobilization begins with dissection of gastrocolic omentum, preserving the right gastric epiploic vascular arcade. By ultrasonic coagulation (Ultracision, USSC, Norwalk, CT, USA), short gastric vessels are divided up to the left diaphragm. With a gentle retraction, the stomach is pulled up and the epiploic retrocavity is reached. Gastropancreatic adhesions are dissected up to the left gastric vessels and ligated by hemoclips. The gastrohepatic ligament is divided along the lesser curvature, always with preservation of the right vascular arcade. Then the mediastinal dissection is started.
The phrenoesophageal ligament is divided, and retroesophageal attachments are debrided. The abdominal esophagus is completely mobilized, and the anterior and posterior branches of the vagus nerve are sectioned. The mediastinal preparation is performed by ultrasonic scalpel under direct vision. All the mediastinal fat and lymphatic tissue are clearly dissected. The esophageal mobilization is continued up to the tracheal bifurcation (Fig. 2). The endoscope placed in the esophageal lumen is of great advantage for identifying the tumor margins and the level of superior dissection. A circular esophageal mobilization above the tumor level, as wide as possible, is achieved.
The neck dissection is performed through a left lateral incision with the head turned to the right. The cervical esophagus is identified, and then a blunt dissection is performed to mobilize the upper substernal portion, completing esophageal liberation. Under laparoscopic visualization, the stomach is transposed in the neck, with attention focussing on the vascular axis and without performing either piloromyotomy or tubulization (Fig. 3). Then the esophagus is sectioned just below the cardia, and esophagectomy is performed.
Cervical anastomosis is realized in the following manner. In the first 11 cases of the current series, a mechanical end-to-end esophagogastric anastomosis was performed using a 25-mm EEA stapler (USSC, Norwalk, CT, USA).For the last 11 patients, we preferred to perform a side-to-side anastomosis using a 60–3.5-mm Endo-GIA II (USSC).
A linear TA stapler device is used to close the defect in the esophageal and gastric wall (Fig. 4). An endoscopic control of the anastomosis is performed. A nasogastric tube is routinely positioned in the distal stomach to prevent respiratory complications caused by gastric distension. A mediastinal suction drain is placed through the hiatus at the end of the procedure. If a pneumothorax occurs, a thoracic drain is placed under laparoscopic visualization.
During the postoperative hospital stay, total parenteral nutrition via a central venous catheter is realized. A gastrografin swallow is performed on postoperative day 7 to check cervical anastomosis and gastric emptying. The patient then is able to start a liquid diet and is discharged home 2 to 3 days later.
Results
The success of neoadjuvant treatment was evaluated by endoscopic ultrasound. The response to preoperative chemoradiation was defined as at least a 50% reduction in the maximal cross-sectional area of the tumor. Of the 35 patients observed, 22 (62.9%) showed a positive response and underwent surgery. Because 13 of patients (9 T4N1 and T3N1) had no response to neoadjuvant treatment, they were submitted to palliative procedures.
All the interventions were completed using the laparoscopic approach. No intraoperative mortality was observed. Pleural perforations occurring in four patients (18.2%) were treated with a thoracic aspiration drainage at the end of the procedure. The mean duration of surgery was 160 min (range, 150–260 min), and the mean blood loss was 400 ml (range, 200–750 ml). Transfusions were required for only two patients. Three patients were admitted to intensive care unit for ventilatory support at the end of the surgical procedure (two patients for 24 h and one patient for 48 h).
Perioperative morbidity included one cervical anastomotic leak (4.5%) among the first patients, which was managed conservatively. No postoperative leak was evident when a side-to-side esophagogastric anastomosis was performed. Two patients (9.1%) experienced delayed gastric emptying, with spontaneous resolution after 1 to 2 weeks. One patient (4.5%) reported recurrent laryngeal nerve injury.
Three patients (13.6%) died, one suddenly of myocardial infarction on postoperative day 15, and two of acute respiratory failure (one pulmonary embolism on the postoperative day 12 and one on postoperative day 14 as well as one bacterial pneumonia on postoperative day 5. No aspiration pneumonia was observed.
The mean number of lymph nodes relieved in the specimen was 8 (range, 2–11). The final pathologic staging was as follows: four T2N0, four T2N1, three T3N0, and nine T3N1. In two cases, a complete disappearance of residual disease was observed in the specimen. The surgical margins were microscopically disease free in all cases. The mean postoperative hospital stay was 12.1 days (range, 9–23 days).
At a mean follow-up of 20.2 months (range, 10–40 months), 13 patients (68.4%) were still alive: 9 disease free and 4 with distant cancer recurrence. The remaining six patients died of metastatic cancer during the first two postoperative years.
The median disease-free survival time, according to Kaplan–Meyer testing, was 23.7 months. The global survival curve, including operative-related mortality, is shown in Fig. 5.
Discussion
Despite progress in anesthesia and postoperative care, open conventional esophagectomy using thoracotomy still is associated with high morbidity (60–84%) and mortality (2–10%) rates [13, 25, 46], especially subsequent to pulmonary complications. Delay of diagnosis and rapid metastatic spread offer very low possibilities of determinative therapeutic interventions. The necessity of an aggressive therapy to achieve an improvement in the long-term survival rates has been supported by many authors. These authors have stressed the need for esophagectomy associated with two-field lymphadenectomy, defined as a radical resection of abdominal and thoracic lymph nodes. Furthermore, several esophageal centers, particularly in Japan, have used a more radical treatment, the threefield lymphadenectomy, including dissection of cervical nodes [2, 22, 27]. Isono et al. [22] reported a 56% 5-year survival rate for patients with a negative three-field lymph node dissection, and a 30% 5-year survival rate for patients with metastatic cervical lymph nodes. Nishihira et al. [27] observed an improvement in the long-term survival for patients who underwent an extended lymphadenectomy, as compared with conventional procedure (66.2% vs 48%), but the difference was not statistically significant (p = 0.192).
In clear contrast to this surgical trend, Orringer and Sloan [31] purposed a less invasive surgical procedure: the transhiatal esophagectomy without associated thoracotomy. In their opinion, a careful mediastinal and thoracic lymph node dissection can improve cancer staging but not survival. In effect, lymph nodal involvement represents a negative survival prognostic factor in all the series. The long-term survival results in the Orringer and Sloan [31] study (27% at a 5-year follow-up assessment) (30) are comparable with those reported after transthoracic esophagectomy. Other series seem to confirm these results, with no statistically significant differences in the long-term survival between transthoracic and transhiatal esophagectomy [14, 19, 32, 42]. Table 1 presents the 5-year survival rates for the surgical techniques in the various series.
The development of mini-invasive surgery at the beginning of the 1990 s gained a consensus for a mini-invasive approach to esophagectomy. Two different techniques have been used more frequently: thoracoscopic esophageal mobilization [7, 9, 37] and the laparoscopic approach [10, 24, 39]. No clear advantages have been demonstrated in terms of postoperative morbidity and mortality for the thoracoscopic approach, as compared with thoracotomy [18, 34], and in some cases, the mortality has been relevant [37]. In particular, pulmonary complications have not been significantly different. In effect, the anesthesiologic techniques, single-lung ventilation, and lateral decubitus are the same among the thoracotomic and thoracoscopic groups, and potential beneficial effects of smaller thoracic incisions are difficult to demonstrate.
In contrast, laparoscopic esophagectomy series reported in literature [10, 24, 39] have demonstrated that minimally invasive esophagectomy is technically feasible and safe in centers with advanced mini-invasive experience, resulting in low postoperative morbidity and mortality rates. The series concerned either benign (advanced achalasia, esophageal reflux stricture) or malignant conditions (adenocarcinoma and squamous cell carcinoma) and showed no difference in terms of postoperative outcome between the two groups.
The oncologic role of laparoscopy still raises major concerns, especially with regard to the possible influence on the development of port-site metastases. In the absence of conclusions for the argument, we preferred to include in our series only patients affected by a locally advanced esophageal squamous cell carcinoma (T3-T4 Nx-N1) with a poor long-term prognosis.
All the patients in our series received preoperative chemoradiotherapy (CT-RT). The addition of preoperative to radiation therapy may downstage disease and facilitate surgical resection, improving local control and reducing the rate of micrometastatic disease [48]. This approach has been shown to result in a pathologic complete response rate of 20% to 30%, a median survival of 16 to 24 months, and a therapy-related mortality of 10% to 12% [35].
Some randomized trials have compared preoperative chemoradiotherapy with surgery alone. Walsh et al. reported [49] a significantly better long-term survival for patients treated with multimodal therapy (52%, 37%, and 32% alive at 1, 2, and 3, years vs 44%, 26%, and 6% in the surgical group). Bosset et al. [5] observed that neoadjuvant treatment did not improve overall survival, but did prolong disease-free survival. Instead, Urba et al. [45] did not demonstrate a statistically significant survival difference for preoperative chemoradiotherapy. Nevertheless, in a recent phase 2 trial (44) with the administration of a preoperative regimen of cisplatin, paclixatel, and radiotherapy, the same authors observed a complete histologic response in the resected specimen from 19% of patients, who demonstrated 1-, 2-, and 3-year survival probabilities of 75%, 50%, and 34%, respectively. In our series, endoscopic ultrasound showed a positive response to chemoradiotherapy in 22 of 35 patients (62.9%), with more than a 50% reduction on the maximal cross-sectional area of the tumor. We preferred this type of evaluation because endoscopic ultrasound has a low sensitivity for assessing TNM staging after neoadjuvant therapy [6, 21]. Nevertheless, we also achieved an effective histologic cancer downstaging in 15 of 22 patients (68.2%).
Our 2-year survival rates (68.4%) are comparable with those reported in other series, both laparoscopic and open. Furthermore, no port-site metastases were observed, and the reported recurrence rates are compatible with the advanced disease of these patients and not dependent, in our opinion, on the surgical approach. The operative time was not influenced by the laparoscopic approach, and we believe the duration of the surgical procedure was acceptable.
Blood loss was minimal, and only two patients were transfused. The direct visualization of the mediastinal space and the use of ultrasonic coagulating shears also allowed coagulation of minimal blood vessels to the superior margin of the tumor. Blunt dissection was limited to the mediastinal space immediately below the cervical incision, and was performed in a space free of tumoral infiltration.
Most authors strongly support the need for a piloromyotomy or a gastric tubularization, believing that they can improve the rate of gastric emptying [ 4, 13]. In our opinion this is not mandatory, and we agree with other authors [8] who relieved a normal motility of the transposed stomach. It is more physiologic for the preservation of gastric integrity, avoiding the section of blood vessels along the lesser curvature. Furthermore, piloromyotomy can increase bile reflux without improving the rate of gastric emptying. In our series, only two patients (9.1%) experienced delayed gastric emptying, with spontaneous resolution after 1 to 2 weeks, and no patient presented with digestive troubles at the long-term follow-up visit.
Changing the performance of esophagogastric anastomosis in the manner described by Orringer et al. [29] greatly contributed to a decreased incidence of anastomotic leak in our series. Whereas one patient among the first 11 (9.1%) experienced a cervical anastomotic leak, this complication was not observed among the last 11 patients. Our data seem to confirm the results described by Orringer et al. [29], who reported a 2.7% rate of anastomotic leak in his last 111 patients, as compared with a 10% to 15% rate for the manually sewn anastomosis in 1,000 patients.
Despite the encouraging data regarding long-term survival and functional results, our postoperative mortality rate (13.6%) is disappointing. This rate is largely attributable to respiratory troubles that arose in the first 2 postoperative weeks. The advanced disease stage can partially explain these events, but they probably are primarily the result of our learning curve. All 3 patients who died were among the first 10 patients, whereas no death was observed in the last 12 patients who underwent surgery.
Also, the hospital stay did not differ significantly from that experienced with the open approach (12.1 days). Respiratory troubles greatly prolonged the median length of the hospital stay. We hope that with more experience our results will ameliorate. However, most patients avoided time on a ventilator and a stay in the intensive care unit, and their recovery was very short. They resumed quotidian activities in 2 to 3 weeks.
Conclusions
Our early experience with laparoscopic esophagectomy demonstrates the feasibility of this approach in the palliative treatment of locally advanced esophageal cancer. Our mortality rate is dependent, on our opinion, on the advanced disease and the learning curve for this challenging procedure.
Oncologic safety of laparoscopy is far from being demonstrated, but laparoscopy could represent a viable alternative in the treatment of these patients with a poor prognosis. It has a clear advantage in terms of postoperative assistance and recovery. However, more extensive trials are necessary to confirm any advantages over the traditional approach, and to obtain standardization of the technique.
References
NK Altorki L Girardi DB Skinner (1997) ArticleTitleEn bloc esophagectomy improves survival for stage III esophageal cancer J Thorac Cardiovasc Surg 114 948–955 Occurrence Handle1:STN:280:DyaK1c%2Fps1ejsQ%3D%3D Occurrence Handle10.1016/S0022-5223(97)70009-6 Occurrence Handle9434690
NK Altorki DB Skinner (1997) ArticleTitleOccult cervical nodal metastasis in esophageal cancer: preliminary results of three-field lymphadenectomy J Thorac Cardiovasc Surg 113 540–554 Occurrence Handle1:STN:280:DyaK2s3js1Wrug%3D%3D Occurrence Handle10.1016/S0022-5223(97)70368-4 Occurrence Handle9081100
N Ando S Ozawa Y Kitagawa Y Shinozawa M Kitajima (2000) ArticleTitleImprovement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years Ann Surg 232 225–232 Occurrence Handle1:STN:280:DC%2BD3cvgvVGltg%3D%3D Occurrence Handle10.1097/00000658-200008000-00013 Occurrence Handle10903602 Occurrence Handle1421135
WA Bemelman CW Taat JF Slors JJ Lanschot Particlevan H Obertop (1995) ArticleTitleDelayed postoperative emptying after esophageal resection is dependent on the size of gastric substitute J Am Coll Surg 180 461–464 Occurrence Handle1:STN:280:DyaK2M3jsFymug%3D%3D Occurrence Handle7719551
JF Bosset M Gignoux JP Triboulet E Triet G Mantion D Elias P Lozach JC Olilier JJ Pavy M Mercier T Sahmoud (1997) ArticleTitleChemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus N Engl J Med 337 161–167 Occurrence Handle1:STN:280:DyaK2szkslaitA%3D%3D Occurrence Handle10.1056/NEJM199707173370304 Occurrence Handle9219702
A Chak MI Canto GS Cooper G Isenberg J Willis N Levitan J Clayman A Forastiere E Heath MV Sivak (2000) ArticleTitleEndosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients Cancer 88 1788–1795 Occurrence Handle1:STN:280:DC%2BD3c3isFGruw%3D%3D Occurrence Handle10.1002/(SICI)1097-0142(20000415)88:8<1788::AID-CNCR5>3.0.CO;2-6 Occurrence Handle10760753
J Collard B Lengele J Otte P Kestens (1993) ArticleTitleEn bloc and standard esophagectomies by thoracoscopy Ann Thorac Surg 56 675–679 Occurrence Handle1:STN:280:DyaK3szptleitQ%3D%3D Occurrence Handle10.1016/0003-4975(93)90949-I Occurrence Handle8379769
JM Collard R Romagnoli JB Otte PJ Kestens (1998) ArticleTitleThe denervated stomach as an esophageal substitute is a contractile organ Ann Surg 227 33–39 Occurrence Handle1:STN:280:DyaK1c7gsFymsA%3D%3D Occurrence Handle10.1097/00000658-199801000-00005 Occurrence Handle9445107 Occurrence Handle1191169
A Cuschieri S Shimi S Banting (1992) ArticleTitleEndoscopic esophagectomy through a right thoracoscopic approach J R Coll Surg Edinb 77 845–857
A Paula ParticleDe K Hashiba E Ferreira R Paula ParticleDe E Grecco (1995) ArticleTitleLaparoscopic transhiatal esophagectomy with esophagogastroplasty Surg Laparosc Endosc 5 1–5 Occurrence Handle10.1089/lps.1995.5.1 Occurrence Handle7735533
SB Dudhat SR Shinde (1998) ArticleTitleTranshiatal esophagectomy for squamous cell carcinoma of the esophagus Dis Esophagus 11 226–230 Occurrence Handle1:STN:280:DyaK1M7ntFWqtQ%3D%3D Occurrence Handle10071803
W Fang H Igaki Y Tachimori H Sato H Daiko H Kato (2001) ArticleTitleThree-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age Ann Thorac Surg 72 867–871 Occurrence Handle1:STN:280:DC%2BD3MrhvVOrtw%3D%3D Occurrence Handle10.1016/S0003-4975(01)02896-X Occurrence Handle11565672
FJ Finley A Lamy J Clifton KG Evans G Fradet B Nelems (1995) ArticleTitleGastrointestinal function following esophagectomy for malignancy Am J Surg 169 471–475 Occurrence Handle1:STN:280:DyaK2M3ms1KksA%3D%3D Occurrence Handle10.1016/S0002-9610(99)80197-4 Occurrence Handle7747821
M Fok S Law F Stipa S Cheng J Wong (1993) ArticleTitleA comparison of transhiatal and transthoracic resection for esophageal carcinoma Endoscopy 25 660–663 Occurrence Handle1:STN:280:DyaK2c7msVSqtw%3D%3D Occurrence Handle10.1055/s-2007-1010427 Occurrence Handle8119227
M Fok S Law J Wong (1994) ArticleTitleOperable esophageal carcinoma: current results from Hong Kong World J Surg 18 355–360 Occurrence Handle1:STN:280:DyaK2cznvVKgsg%3D%3D Occurrence Handle10.1007/BF00316814 Occurrence Handle8091775
S Galandiuk RE Hermann DM Cosgrove JJ Gassman (1986) ArticleTitleCancer of the esophagus: the Cleveland Clinic Experience Ann Surg 203 101–108 Occurrence Handle1:STN:280:DyaL287gt1altA%3D%3D Occurrence Handle10.1097/00000658-198601000-00016 Occurrence Handle3942414 Occurrence Handle1251045
GA Gelfand FJ Finley B Nelems R Inculet KG Evans G Fradet (1992) ArticleTitleTranshiatal esophagectomy for carcinoma of the esophagus and cardia: Experience with 160 cases Arch Surg 127 1164–1167 Occurrence Handle1:STN:280:DyaK3s%2FjvVSquw%3D%3D Occurrence Handle10.1001/archsurg.1992.01420100022004 Occurrence Handle1417480
D Gossot P Cattan S Fritsch B Halimi E Sarfati M Celerier (1995) ArticleTitleCan the morbidity of esophagectomy be reduced by the thoracoscopic approach? Surg Endosc 9 1113–1115 Occurrence Handle1:STN:280:DyaK287hvVWjtg%3D%3D Occurrence Handle10.1007/BF00188998 Occurrence Handle8553214
O Horstmann PR Verreet H Becker C Ohmann HD Roher (1995) ArticleTitleTranshiatal esophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of esophageal cancer Eur J Surg 161 557–567 Occurrence Handle1:STN:280:DyaK28%2FlsFamtQ%3D%3D Occurrence Handle8519871
M Ikeguchi M Maeta N Kaibara (2000) ArticleTitleLimited operation for patients with T1esophageal cancer Arch Surg 385 454–458 Occurrence Handle1:STN:280:DC%2BD3M7hsVOktQ%3D%3D Occurrence Handle10.1007/s004230000173
G Isenberg A Chak MI Canto N Levitan J Clayman BJ Pollack MV Sivak (1998) ArticleTitleEndoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation Gastrointest Endosc 48 158–163 Occurrence Handle1:STN:280:DyaK1czotFyrsw%3D%3D Occurrence Handle10.1016/S0016-5107(98)70157-9 Occurrence Handle9717781
K Isono HK Sato K Nakayama (1991) ArticleTitleResults of nationwide study on the three-field lymph node dissection of esophageal cancer Oncology 48 411–420 Occurrence Handle1:STN:280:DyaK38%2FotVamtQ%3D%3D Occurrence Handle10.1159/000226971 Occurrence Handle1745490
P Lozac’h P Topart M Perramant (1997) ArticleTitleIvor Lewis procedure for epidermoid carcinoma of the esophagus: a series of 264 patients Semin Surg Oncol 13 238–244 Occurrence Handle10.1002/(SICI)1098-2388(199707/08)13:4<238::AID-SSU4>3.3.CO;2-G Occurrence Handle9229410
JD Luketich PR Schauer NA Christie TL Weigel S Raja HC Fernando RJ Keenan NT Nguyen (2000) ArticleTitleMinimally invasive esophagectomy Ann Thorac Surg 70 906–912 Occurrence Handle1:STN:280:DC%2BD3cvmtlGjsA%3D%3D Occurrence Handle10.1016/S0003-4975(00)01711-2 Occurrence Handle11016332
DJ Mathisen HC Grille EW Wilkins SuffixJr AC Moncure AD Hilgenberg (1988) ArticleTitleTransthoracic esophagectomy: a safe approach to carcinoma of the esophagus Ann Thorac Surg 45 137–143 Occurrence Handle1:STN:280:DyaL1c7jtlSrsw%3D%3D Occurrence Handle10.1016/S0003-4975(10)62424-1 Occurrence Handle3277551
JM Muller H Erasmi M Stelzner U Zieren H Pichlmaier (1990) ArticleTitleSurgical therapy of esophageal carcinoma Br J Surg 77 845–857 Occurrence Handle1:STN:280:DyaK3czms1ymuw%3D%3D Occurrence Handle10.1002/bjs.1800770804 Occurrence Handle2203505
T Nishihira K Hirayama S Mori (1998) ArticleTitleA prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus Am J Surg 175 47–51 Occurrence Handle1:STN:280:DyaK1c7gs1SitQ%3D%3D Occurrence Handle10.1016/S0002-9610(97)00227-4 Occurrence Handle9445239
MB Orringer B Marshall MD Iannettoni (1999) ArticleTitleTranshiatal esophagectomy: clinical experience and refinements Ann Surg 230 392–400 Occurrence Handle1:STN:280:DyaK1MvitFahuw%3D%3D Occurrence Handle10.1097/00000658-199909000-00012 Occurrence Handle10493486 Occurrence Handle1420884
MB Orringer B Marshall MD Iannettoni (2000) ArticleTitleEliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis J Thorac Cardiovasc Surg 119 277–288 Occurrence Handle1:STN:280:DC%2BD3c7hsFOnug%3D%3D Occurrence Handle10.1016/S0022-5223(00)70183-8 Occurrence Handle10649203
MB Orringer B Marshall MC Stirling (1993) ArticleTitleTranshiatal esophagectomy for benign and malignant disease J Thorac Cardiovasc Surg 105 265–276 Occurrence Handle1:STN:280:DyaK3s7ls1eitw%3D%3D Occurrence Handle8429654
MB Orringer H Sloan (1978) ArticleTitleEsophagectomy without thoracotomy J Thorac Cardiovasc Surg 76 643–654 Occurrence Handle1:STN:280:DyaE1M%2FjtV2rsg%3D%3D Occurrence Handle703369
M Paç A Basoglu H Koçak I Yekeler S Yediyildiz E Aydin A Yihnaz N Okçu M Keles (1993) ArticleTitleTranshiatal versus transthoracic esophagectomy for esophageal cancer J Thorac Cardiovasc Surg 106 205–209 Occurrence Handle8341062
PP Paricio JA Garcia Marcilla L Martinez Haro Particlede MA Ortiz Escandell G Castellanos Escrig (1993) ArticleTitleResults of surgical treatment of epidermoid carcinoma of the thoracic esophagus Surg Gynecol Obstet 177 398–404 Occurrence Handle1:STN:280:DyaK2c%2FisVCmsw%3D%3D Occurrence Handle7692612
A Peracchia R Rosati U Fumagalli S Bona B Chella (1997) ArticleTitleThoracoscopic esophagectomy: are there benefits? Semin Surg Oncol 13 259–262 Occurrence Handle1:STN:280:DyaK2szntlertg%3D%3D Occurrence Handle10.1002/(SICI)1098-2388(199707/08)13:4<259::AID-SSU7>3.0.CO;2-4 Occurrence Handle9229413
E Poplin T Fleming L Leichman HG Seydel Z Steiger S Taylor R Vance WG Stuckey SE Rivkin (1987) ArticleTitleCombined therapies for squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study 8037 J Clin Oncol 5 622–628 Occurrence Handle1:STN:280:DyaL2s7mvVGksQ%3D%3D Occurrence Handle3559653
R Rindani CJ Martin MR Cox (1999) ArticleTitleTranshiatal versus Ivor–Lewis esophagectomy: is there a difference? Aust N Z J Surg 69 187–194 Occurrence Handle1:STN:280:DyaK1M7ntlKkuw%3D%3D Occurrence Handle10.1046/j.1440-1622.1999.01520.x Occurrence Handle10075357
GSM Robertson D Lloyd A Wicks P Veitch (1996) ArticleTitleNo obvious advantages for thoracoscopic two-stage esophagectomy Br J Surg 83 675–678 Occurrence Handle1:STN:280:DyaK283ps1amsA%3D%3D Occurrence Handle10.1002/bjs.1800830527 Occurrence Handle8689217
DB Skinner (1995) En bloc resection for esophageal carcinoma FG Pearson (Eds) Esophageal surgery Churchill Livingstone New York 709–718
L Swanstrom P Hansen (1997) ArticleTitleLaparoscopic total esophagectomy Arch Surg 132 943–949 Occurrence Handle1:STN:280:DyaK2svkslWmtg%3D%3D Occurrence Handle10.1001/archsurg.1997.01430330009001 Occurrence Handle9301605
Y Tabira N Kitamura M Yoshioka M Tanaka K Nakano N Toyota T Mori (1999) ArticleTitleSignificance of three-field lymphadenectomy for carcinoma of the thoracic esophagus based on depth of tumor infiltration, lymph node involvement, and survival rate J Cardiovasc Surg 40 737–740 Occurrence Handle1:STN:280:DC%2BD3c%2Fmt1Wmsg%3D%3D
M Tachibana S Kinugasa DK Dhar T Kotoh M Shibakita S Ohno R Masunaga H Kubota H Kohno N Nagasue (1999) ArticleTitlePrognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus J Surg Oncol 72 88–93 Occurrence Handle1:STN:280:DyaK1Mvkslymtw%3D%3D Occurrence Handle10.1002/(SICI)1096-9098(199910)72:2<88::AID-JSO9>3.0.CO;2-V Occurrence Handle10518105
HW Tilanus WC Hop BL Langerhorst JJ Lanschot Particlevan (1993) ArticleTitleEsophagectomy with or without thoracotomy: is there any difference? J Thorac Cardiovasc Surg 105 898–903 Occurrence Handle1:STN:280:DyaK3s3lsVSktg%3D%3D Occurrence Handle8487568
H Udagawa H Akiyama (2001) ArticleTitleSurgical treatment of esophageal cancer: Tokyo experience of the three-field technique Dis Esophagus 14 110–114 Occurrence Handle1:STN:280:DC%2BD3MrgtlOksQ%3D%3D Occurrence Handle10.1046/j.1442-2050.2001.00166.x Occurrence Handle11553219
SG Urba MB Orringer M lannettoni JA Hayman H Satoru (2003) ArticleTitleConcurrent cisplatin, paclixatel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma Cancer 98 2177–2183 Occurrence Handle1:CAS:528:DC%2BD3sXps1ars74%3D Occurrence Handle10.1002/cncr.11759 Occurrence Handle14601087
SG Urba MB Orringer A Turrisi M Iannettoni A Forastiere M Strawderman (2001) ArticleTitleRandomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 305–313 Occurrence Handle1:CAS:528:DC%2BD3MXhtVektrs%3D Occurrence Handle11208820
JD Urschel (1995) ArticleTitleEsophagogastrostomy anastomotic leaks complicatmg esophagectomy: a review Am J Surg 169 634–640 Occurrence Handle1:STN:280:DyaK2M3ovFGltA%3D%3D Occurrence Handle10.1016/S0002-9610(99)80238-4 Occurrence Handle7771633
WT Vigneswaran VF Trastek PC Pairolero C Deschamps RC Daly MS Alien (1993) ArticleTitleTranshiatal esophagectomy for carcinoma of the esophagus, Ann Thorac Surg 56 838–844 Occurrence Handle1:STN:280:DyaK2c%2FivFansQ%3D%3D Occurrence Handle10.1016/0003-4975(93)90341-E Occurrence Handle8215660
SB Vogel WM Mendenhall MD Sombeck R Marsh ER Woodward (1995) ArticleTitleDownstaging of esophageal cancer after preoperative radiation and chemotherapy Ann Surg 221 385–395 Occurrence Handle10.1097/00000658-199506000-00008
TN Walsh N Noonan D Hollywood A Kelly N Keeling TP Hennessy (1996) ArticleTitleA comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462–467 Occurrence Handle1:STN:280:DyaK283psF2juw%3D%3D Occurrence Handle10.1056/NEJM199608153350702 Occurrence Handle8672151
AS Woronoff M Mercier M Gignoux JP Triboulet G Chaillard JF Bosset (1998) ArticleTitleFacteurs pronostiques des cancers epidermoides de I’esophage operables Gastroenterol Clin Biol 22 168–174 Occurrence Handle1:STN:280:DyaK1cvjsV2guw%3D%3D Occurrence Handle9762191
C Wu Z Zhang H Xue (1996) ArticleTitleResults on Ivor–Lewis esophagogastrectomy for 338 cases of carcinoma of esophagus Zhonghua Zhong Liu Za Zhi 18 192–194 Occurrence Handle1:STN:280:DyaK1c%2FkvVCqug%3D%3D Occurrence Handle9387252
Acknowledgments
The authors offer a special thanks to doctor Giuseppe Signoriello for statistical analysis of our work and to all the nursing staff of operating theater.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Del Genio, A., Rossetti, G., Napolitano, V. et al. Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy. Surg Endosc 18, 1789–1794 (2004). https://doi.org/10.1007/s00464-003-9243-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-003-9243-1